SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
6-K
REPORT OF
FOREIGN ISSUER
Pursuant
to Rule 13a-16 or 15d-16 of
the
Securities Exchange Act of 1934
For
the month of April 2005
Commission
File Number 000-51122
pSivida
Limited
(Translation of registrant’s name into English)
(Translation of registrant’s name into English)
Level 12
BGC Centre
28 The
Esplanade
Perth WA
6000
(Address
of principal executive offices)
(Indicate
by check mark whether the registrant files or will file annual reports under
cover Form 20-F or Form 40-F).
Form 20-F
ý Form
40-F o
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted
by Regulation S-T Rule 101(b)(1):
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted
by Regulation S-T Rule 101(b)(7):
Indicate
by check mark whether the registrant by furnishing the information contained in
this Form is also thereby furnishing the information to the Commission pursuant
to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes
o No
ý
If "Yes"
is marked, indicate below the file number assigned to the registrant in
connection with Rule 12g3-2(b): 82- ___.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant,
pSivida Limited, has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
Date:
April 22, 2005
| pSivida Limited | ||
| |
|
|
| By: | /s/ Aaron Finlay | |
|
Aaron
Finlay
Chief
Financial Officer and Company Secretary | ||
EXHIBIT
INDEX
|
EXHIBIT
99.1: |
Quarterly
report for entities admitted on the basis of commitments |
Appendix
4C
Quarterly
report for entities
admitted
on the basis of commitments
Rule 4.7B
Rule 4.7B
Appendix
4C
Quarterly
report
for
entities admitted
on
the basis of commitments
Introduced
31/3/2000. Amended 30/9/2001
Name of entity
|
PSIVIDA
LIMITED |
| ABN | Quarter ended (“current quarter”) |
|
98
009 232 026 |
31
MARCH 2005 |
Consolidated
statement of cash flows
|
Cash
flows related to operating activities |
Current
quarter
$A |
Year
to date
(9
months)
$A |
||||||||
|
1.1
Receipts
from customers |
— |
— |
||||||||
|
1.2
Payments
for (a)
staff
costs (b) advertising and marketing (c) research and development (d) leased assets (e) other working capital |
(184,641
—
(2,057,977
—
(1,300,466 |
)
) ) |
(846,801
—
(5,792,555
—
(2,614,694 |
)
) ) | ||||||
|
1.3
Dividends
received |
— |
— |
||||||||
|
1.4
Interest
and other items of a similar nature received |
163,251 |
547,873 |
||||||||
|
1.5
Interest
and other costs of finance paid |
— |
— |
||||||||
|
1.6
Income
taxes paid |
— |
— |
||||||||
|
1.7
Other
-
GST
(paid)/received - Other Income |
(50,460
141,361 |
) |
(73,874
155,241 |
) | ||||||
|
Net
operating cash flows |
(3,288,932 |
) |
(8,624,810 |
) | ||||||
| + See chapter 19 for
defined terms. 30/9/2001 |
Appendix
4C Page 1 |
Appendix
4C
Quarterly
report for entities
admitted
on the basis of commitments
|
Current
quarter
$A |
Year
to date
(9
months)
$A |
||||
|
1.8 |
Net
operating cash flows (carried forward) |
(3,288,932 |
) |
(8,624,810 |
) |
|
Cash
flows related to investing activities |
|||||
|
1.9 |
Payment
for acquisition of:
(a) businesses (item 5)
(b) equity investments
(c) intellectual property
(d) physical non-current assets
(e) other non-current assets |
—
—
—
(767,354
— |
) |
—
—
—
(2,227,127
— |
) |
|
1.10 |
Proceeds
from disposal of:
(a) businesses (item 5)
(b) equity investments
(c) intellectual property
(d) physical non-current assets
(e) other non-current
assets |
—
—
—
—
— |
—
—
—
—
— |
||
|
1.11 |
Loans
from/(to) other entities |
— |
— |
||
|
1.12 |
Loans
repaid by other entities |
— |
— |
||
|
1.13 |
Other
(provide details if material)
-
Cash paid for equity increase in controlled entity |
— |
(4,644,966 |
) | |
|
Net
investing cash flows |
(767,354 |
) |
(6,872,093 |
) | |
|
1.14 |
Total
operating and investing cash flows |
(4,056,286 |
) |
(15,496,903 |
) |
|
Cash
flows related to financing activities |
|||||
|
1.15 |
Proceeds
from issues of shares, options, etc. |
— |
3,666,500 |
||
|
1.16 |
Proceeds
from sale of forfeited shares |
— |
— |
||
|
1.17 |
Proceeds
from borrowings |
— |
— |
||
|
1.18 |
Repayment
of borrowings |
— |
— |
||
|
1.19 |
Dividends
paid |
— |
— |
||
|
1.20 |
Other
- Share issue costs |
— |
(27,422 |
) | |
|
Net
financing cash flows |
— |
3,639,078 |
|||
|
Net
increase (decrease) in cash held |
(4,056,286 |
) |
(11,857,825 |
) | |
|
1.21 |
Cash
at beginning of quarter/year to date |
22,000,602 |
31,350,656 |
||
|
1.22 |
Exchange
rate adjustments |
(91,384 |
) |
(1,639,899 |
) |
|
1.23 |
Cash
at end of quarter |
17,852,932 |
17,852,932 |
| + See chapter 19 for
defined terms. Appendix 4C Page 2 |
30/9/2001 |
Appendix
4C
Quarterly
report for entities
admitted
on the basis of commitments
Payments
to directors of the entity and associates of the directors
Payments
to related entities of the entity and associates of the related
entities
|
Current
quarter
$A | ||
|
1.24 |
Aggregate
amount of payments to the parties included in item 1.2 |
201,576 |
|
1.25 |
Aggregate
amount of loans to the parties included in item 1.11 |
— |
|
1.26 |
Explanation
necessary for an understanding of the transactions | |
|
1.2(a)
Staff
costs include consultants and directors fees paid by pSivida.
1.2(c)
Research
and development costs include all expenditure incurred by pSiMedica and
pSiOncology.
1.13
Includes amounts transferred for the purposes of funding the research and
development activities of pSiMedica.
1.15
$3,366,500
received on the exercise of options with an expiry date of 31 December
2004.
| ||
Non-cash
financing and investing activities
|
2.1 |
Details
of financing and investing transactions which have had a material effect
on consolidated assets and liabilities but did not involve cash
flows |
|
N/A |
|
2.2 |
Details
of outlays made by other entities to establish or increase their share in
businesses in which the reporting entity has an
interest |
|
N/A |
Financing
facilities available
Add
notes as necessary for an understanding of the position. (See AASB 1026
paragraph 12.2).
|
Amount
available
$A |
Amount
used
$A | ||
|
3.1 |
Loan
facilities |
— |
— |
|
3.2 |
Credit
standby arrangements |
— |
— |
| + See chapter 19 for
defined terms. 30/9/2001 |
Appendix 4C
Page 3 |
Appendix
4C
Quarterly
report for entities
admitted
on the basis of commitments
Reconciliation
of cash
|
Reconciliation
of cash at the end of the quarter (as shown in the consolidated statement
of cash flows) to the related items in the accounts is as
follows. |
Current
quarter
$A |
Previous
quarter
$A | |
|
4.1 |
Cash
on hand and at bank |
2,049,150 |
927,580 |
|
4.2 |
Deposits
at call |
15,803,782 |
21,073,022 |
|
4.3 |
Bank
overdraft |
— |
— |
|
4.4 |
Other
(provide details) |
— |
— |
|
Total:
cash at end of quarter (item
1.23) |
17,852,932 |
22,000,602 | |
Acquisitions
and disposals of business entities
|
Acquisitions
(Item
1.9(a)) |
Disposals
(Item
1.10(a)) | ||
|
5.1 |
Name
of entity |
||
|
5.2 |
Place
of incorporation or registration |
||
|
5.3 |
Consideration
for acquisition
or disposal |
||
|
5.4 |
Total
net assets |
||
|
5.5 |
Nature
of business |
||
Compliance
statement
|
1 |
This
statement has been prepared under accounting policies which comply with
accounting standards as defined in the Corporations Act (except to the
extent that information is not required because of note 2) or other
standards acceptable to ASX. |
|
2 |
This
statement does / |
21 April
2005
Sign
here: ............................................................ Date:
.............................
(Director/Company secretary)
(Director/Company secretary)
Aaron
Finlay
Print
name: .........................................................
| + See chapter 19 for
defined terms. Appendix 4C Page 4 |
30/9/2001 |
Appendix
4C
Quarterly
report for entities
admitted
on the basis of commitments
Notes
Notes
| 1. | The quarterly report provides a basis for informing the market how the entity’s activities have been financed for the past quarter and the effect on its cash position. An entity wanting to disclose additional information is encouraged to do so, in a note or notes attached to this report. |
| 2. | The definitions in, and provisions of, AASB 1026: Statement of Cash Flows apply to this report except for the paragraphs of the Standard set out below. |
| · 6.2 - |
reconciliation
of cash flows arising from operating activities to operating
profit or loss |
| · 9.2 - |
itemised
disclosure relating to acquisitions |
| · 9.4 - |
itemised
disclosure relating to disposals |
| · 12.1(a) - |
policy
for classification of cash items |
| · 12.3 - |
disclosure
of restrictions on use of cash |
| · 13.1 - |
comparative
information |
| 3. | Accounting Standards. ASX will accept, for example, the use of International Accounting Standards for foreign entities. If the standards used do not address a topic, the Australian standard on that topic (if any) must be complied with. |
| + See chapter 19 for
defined terms. 30/9/2001 |
Appendix 4C
Page 4 |